Home/Filings/4/0000899243-19-003299
4//SEC Filing

Semigran Marc 4

Accession 0000899243-19-003299

CIK 0001552451other

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 4:31 PM ET

Size

8.2 KB

Accession

0000899243-19-003299

Insider Transaction Report

Form 4
Period: 2019-02-08
Semigran Marc
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-02-08+24,90024,900 total
    Exercise: $40.11Exp: 2029-02-07Common Stock (24,900 underlying)
  • Award

    Restricted Stock Units

    2019-02-08+8,5008,500 total
    Common Stock (8,500 underlying)
Footnotes (2)
  • [F1]The shares underlying the option vest in 48 equal monthly installments from January 1, 2019, so long as the Reporting Person continues to be an employee of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
  • [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2019, so that all of the underlying shares shall be vested on January 1, 2023, subject to the Reporting Person's continued employment with the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer.

Issuer

MyoKardia Inc

CIK 0001552451

Entity typeother

Related Parties

1
  • filerCIK 0001691494

Filing Metadata

Form type
4
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 4:31 PM ET
Size
8.2 KB